Top Undervalued Stocks To Invest In 2018

In a short period of time readers and I have been pleasantly surprised by the outperformance of this model portfolio.

Click to enlarge Figure 1: Ceviche Fund Snapshot November 19th

While the fund takes a “go anywhere” approach, lately the opportunities we’ve been seeing are in biotech companies that are undervalued relative to their future prospects, with catalysts on the way that could result in near to medium term share price appreciation.

In hindsight, it wasn’t great timing when I started the fund near the beginning of correction in biotech. However, when it comes to the markets in general I don’t try to predict future movement- instead I look for price action, money flow, and the fundamental story on individual stocks I take positions in.

Top Undervalued Stocks To Invest In 2018: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Top Undervalued Stocks To Invest In 2018: InnerWorkings, Inc.(INWK)

Advisors’ Opinion:

  • [By Tom Gentile]

    Now as you can see – and as I mentioned earlier – there’s one that outperforms the others: InnerWorkings Inc. (Nasdaq: INWK):

    INWK is a top marketing firm that services a wide range of Fortune 500 media companies as well as retail, financial, hospitality, automotive, healthcare, and others. It met earnings expectations for the first quarter and fell just short of revenue expectations. Despite that, it’s been steadily climbing:

Top Undervalued Stocks To Invest In 2018: Burcon Nutrascience Corp(BUR)

Advisors’ Opinion:

  • [By William Romov]

    Last Wednesday (Dec. 6), the company received a patent for certain methods of production of its phase 2 antidepressant, AV-101.

    Penny Stock Current Share Price Dec. 4 – Dec. 8 Gain (as of Dec. 8)
    VistaGen Therapeutics Inc. (Nasdaq: VTGN) $1.80 135%
    FXCM Inc. (Nasdaq: GLBR) $1.12 124%
    Neuralstem Inc. (Nasdaq: CUR) $2.00 75.44%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.49 75.29%
    ClearSign Combustion Corp. (Nasdaq: CLIR) $3.50 53.85%
    Astrotech Corp. (Nasdaq: ASTC) $4.21 51.99%
    Burcon NutraScience Corp. (Nasdaq: BUR) $0.72 44%
    LM Funding America Inc. (Nasdaq: LMFA) $3.72 42.53%
    Second Sight Medical Products Inc. (Nasdaq: EYES) $1.75 42.28%
    Globus Maritime Ltd. (Nasdaq: GLBS) $1.47 41.35%

    As a result, its share price shot up from $0.92 to $2.52 on Wednesday. The stock pulled back to $1.80 by the end of the week, for a total gain of 135% for the week.

Top Undervalued Stocks To Invest In 2018: MPLX LP(MPLX)

Advisors’ Opinion:

  • [By Garrett Cook]

    Lastly, Citi says Marathon Petroleum (NYSE: MPC) and MPLX LP (NYSE: MPLX) remain Buy rated the heels of benefits derived from strong product demand and the NGL recovery.

  • [By Ben Levisohn]

    JPMorgan analyst Phil Gresh and team explain what they got wrong about Marathon Petroleum (MPC), as they cut its rating to Neutral from Overweight following yesterday’s disastrous financial results from MPLX (MPLX):

Leave a Reply

Your email address will not be published. Required fields are marked *